|
Gilead Sciences Inc (GILD) |
|
Gilead Sciences Inc Balance Sheet Quarterly
GILD
|
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
|
GILD Balance Sheets
(Quarterly, GAAP in millions $) |
(Jun 30 2024)
II. Quarter |
(Mar 31 2024)
I. Quarter |
(Dec 31 2023)
IV. Quarter |
(Sep 30 2023)
III. Quarter |
(Jun 30 2023)
II. Quarter |
|
ASSETS |
| Cash & cash equivalent |
- |
- |
- |
- |
- |
| Cash, Cash eqvivalents other |
- |
- |
- |
- |
- |
| Marketable Securities, Current SH |
- |
- |
1,179.00 |
1,159.00 |
963.00 |
| Cash
& Short-term Investments |
- |
- |
1,179.00 |
1,159.00 |
963.00 |
| Accounts receivable |
4,663.00 |
4,669.00 |
4,660.00 |
4,790.00 |
4,229.00 |
| Other receivables net |
- |
- |
- |
- |
- |
| Net Receivables |
- |
- |
- |
- |
- |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents |
2,772.00 |
4,718.00 |
6,085.00 |
5,705.00 |
5,704.00 |
| Inventories |
2,026.00 |
1,853.00 |
1,787.00 |
1,663.00 |
1,633.00 |
| Other current assets |
2,772.00 |
4,719.00 |
6,085.00 |
5,706.00 |
5,705.00 |
| Prepaid Expense And Other Assets Current |
2,856.00 |
2,800.00 |
2,374.00 |
2,662.00 |
1,757.00 |
| Total Current Assets |
12,317.00 |
14,041.00 |
16,085.00 |
15,980.00 |
14,287.00 |
| Equipment/Property/Plant Net |
5,346.00 |
5,321.00 |
5,317.00 |
5,572.00 |
5,540.00 |
| Goodwill net |
8,314.00 |
8,314.00 |
8,314.00 |
8,314.00 |
8,314.00 |
| Intangible Assets |
22,832.00 |
23,428.00 |
26,454.00 |
27,152.00 |
27,750.00 |
| Long-term investments |
- |
- |
1,163.00 |
1,156.00 |
1,334.00 |
| Accounts Receivable, Net, Noncurrent |
- |
- |
- |
- |
- |
| Long-term recivables |
- |
- |
- |
- |
- |
| Deferred Tax Assets, Net of Valuation Allowance, Noncurrent |
- |
- |
- |
- |
- |
| Other Assets |
4,770.00 |
5,188.00 |
4,792.00 |
4,199.00 |
5,112.00 |
| Prepaid Expense Other, Noncurrent PR |
- |
- |
- |
- |
- |
| Discontinued operations |
- |
- |
- |
- |
- |
| Total Assets |
53,579.00 |
56,292.00 |
62,125.00 |
62,373.00 |
62,337.00 |
| LIABILITIES |
| Accounts Payable, Current AC |
537.00 |
622.00 |
550.00 |
586.00 |
622.00 |
| Accrued Liabilities, Current AC |
- |
- |
- |
- |
- |
| Accrued expenses |
- |
- |
- |
- |
- |
| Debt, Current LI |
1,810.00 |
3,667.00 |
1,798.00 |
1,793.00 |
4,037.00 |
| Other current liabilities |
8,434.00 |
8,726.00 |
5,130.00 |
5,852.00 |
9,305.00 |
| Accrued Income Taxes, Current TA |
- |
- |
- |
- |
- |
| Deferred Revenue, Current DE |
- |
- |
- |
- |
- |
| Dividends payable |
- |
- |
- |
- |
- |
| Accrued Rebates |
3,923.00 |
4,263.00 |
3,802.00 |
3,714.00 |
3,494.00 |
| Total Current Liabilities |
10,781.00 |
13,015.00 |
11,280.00 |
11,945.00 |
13,964.00 |
| Long-term debt |
21,540.00 |
21,527.00 |
23,189.00 |
23,189.00 |
21,209.00 |
| Capital lease obligations |
- |
- |
- |
- |
- |
| Long-term debt Convertible |
- |
- |
- |
- |
- |
| Total
Long-term Debt |
21,540.00 |
21,527.00 |
23,189.00 |
23,189.00 |
21,209.00 |
| Total def. income & other liab. |
- |
- |
- |
- |
- |
| Employee benefit plans |
- |
- |
- |
- |
- |
| Deferred Revenue, Noncurrent DE |
- |
- |
- |
- |
- |
| Accrued Income Taxes, Noncurrent AC1 |
738.00 |
1,967.00 |
2,039.00 |
2,088.00 |
2,610.00 |
| Discontinued operations |
- |
- |
- |
- |
- |
| Other longterm liabilities |
- |
- |
- |
- |
- |
| Deferred Income Tax Liabilities Net |
907.00 |
933.00 |
1,588.00 |
1,984.00 |
2,106.00 |
| Total Liabilities |
33,059.00 |
36,509.00 |
36,508.00 |
37,222.00 |
37,783.00 |
SHAREHOLDER'S EQUITY |
| Common Stock Value |
1.00 |
1.00 |
1.00 |
1.00 |
1.00 |
| Additional Paid In Capital Common Stock |
7,022.00 |
6,813.00 |
6,500.00 |
6,279.00 |
6,008.00 |
| Retained Earnings / Accumulated Deficit |
11,165.00 |
10,656.00 |
16,304.00 |
16,002.00 |
15,138.00 |
| Other Equity |
93.00 |
69.00 |
28.00 |
32.00 |
11.00 |
| Noncontrolling interests & other |
-84.00 |
-84.00 |
-84.00 |
-72.00 |
-64.00 |
| Total
Stockholder's Equity |
18,197.00 |
17,455.00 |
22,749.00 |
22,242.00 |
21,094.00 |
| Liabilities & Stockholder's
Equity |
53,579.00 |
56,292.00 |
62,125.00 |
62,373.00 |
62,337.00 |
|
|
